Talk to Alison

00 1 718 618 48 97

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Pathology Analysis & Statistics, May 2013 (p40)

You might be interested in: cancer, breast cancer, prostate cancer, more »

» Purchase Premium Reports

1171-1210 of about 4 800 reports

Austria Peptic Ulcer Disease, 45-59 Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pathology
  • Countries : Austria

Norway Peptic Ulcer Disease, 45-59 Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pathology
  • Countries : Norway

Palau Post-traumatic Stress Disorder, 45-59 Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pathology
  • Countries : World

Iraq Prostate Cancer, 45-59 Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pathology
  • Countries : Iraq, World

Lesotho Post-traumatic Stress Disorder, 15-29 Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pathology
  • Countries : Lesotho

Belgium Protein-energy Malnutrition, 70+ Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pathology
  • Countries : Belgium

Paraguay Prostate Cancer, 70+ Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pathology
  • Countries : Paraguay

Honduras Prostate Cancer, 70+ Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pathology
  • Countries : Honduras

Dominican Republic Post-traumatic Stress Disorder, 30-44 Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pathology
  • Countries : Dominican Republic, Dominica

Papua New Guinea Schistosomiasis, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pathology
  • Countries : Papua New Guinea, Guinea
GeoPharma, Inc. (Symbol:GORX) SWOT Analysis, Strategy, Revenues and Profits

GeoPharma, Inc. (Symbol:GORX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Inhibitex, Inc. (Symbol:INHX) SWOT Analysis, Strategy, Revenues and Profits

Inhibitex, Inc. (Symbol:INHX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Stallergenes S.A. (Symbol:GENP) SWOT Analysis, Strategy, Revenues and Profits

Stallergenes S.A. (Symbol:GENP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Ego Pharmaceuticals Pty Ltd SWOT Analysis, Strategy, Revenues and Profits

Ego Pharmaceuticals Pty Ltd SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia, Singapore, World
Orexo AB (Symbol:ORX) SWOT Analysis, Strategy, Revenues and Profits

Orexo AB (Symbol:ORX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Medivation, Inc. (Symbol:MDVN) SWOT Analysis, Strategy, Revenues and Profits

Medivation, Inc. (Symbol:MDVN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Probiomics Ltd. (Symbol:PCC) SWOT Analysis, Strategy, Revenues and Profits

Probiomics Ltd. (Symbol:PCC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
Novo Nordisk A/S (NOVO B) - Financial and Strategic SWOT Analysis Review

Novo Nordisk A/S (NOVO B) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • November 2012
  • by Global Data

Summary Novo Nordisk A/S (Novo Nordisk) is a global healthcare company. It undertakes the development, manufacture and marketing and distribution of diabetes care products. The company also develops drugs ...

  • Industries : Pathology
  • Countries : United States
BioInvent International AB (Symbol:BINV) SWOT Analysis, Strategy, Revenues and Profits

BioInvent International AB (Symbol:BINV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
H. Lundbeck A/S (LUN) - Financial and Strategic SWOT Analysis Review

H. Lundbeck A/S (LUN) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • November 2012
  • by Global Data

Summary H. Lundbeck A/S (Lundbeck) is a pharmaceutical company, involved in the research, development, manufacturing and marketing of pharmaceuticals for the treatment of diseases related to the central ...

  • Industries : Pathology
  • Countries : Europe, Denmark, United States
Huons Co., Ltd. (Symbol:084110) SWOT Analysis, Strategy, Revenues and Profits

Huons Co., Ltd. (Symbol:084110) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Advanced Life Sciences Holdings, Inc. (ADLS) - Financial and Strategic SWOT Analysis Review

Advanced Life Sciences Holdings, Inc. (ADLS) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • November 2012
  • by Global Data

Summary Advanced Life Sciences Holdings, Inc. (Advanced Life Sciences) engages in the discovery, development, and commercialization of drugs in the areas of infectious disease, inflammation, and oncology. ...

  • Industries : Pathology
  • Countries : United States
Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review

Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • November 2012
  • by Global Data

Summary Panacea Biotec Limited (Panacea) is a research-based biotechnology company that carries out development, manufacturing and commercialization of novel prescription products. The company operates ...

  • Industries : Pathology
  • Countries : India, Nigeria
NeuroSearch A/S (NEUR) - Financial and Strategic SWOT Analysis Review

NeuroSearch A/S (NEUR) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • November 2012
  • by Global Data

Summary NeuroSearch A/S (NeuroSearch) is a biopharmaceutical company that develops novel pharmaceutical agents for the treatment of various life threatening diseases. It mainly focuses on finding treatment ...

  • Industries : Pathology
Insmed Incorporated (Symbol:INSM) SWOT Analysis, Strategy, Revenues and Profits

Insmed Incorporated (Symbol:INSM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Neurologix, Inc. (Symbol:NRGX) SWOT Analysis, Strategy, Revenues and Profits

Neurologix, Inc. (Symbol:NRGX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
4SC AG (Symbol:VSC) SWOT Analysis, Strategy, Revenues and Profits

4SC AG (Symbol:VSC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
BioAlliance Pharma SA (Symbol:BIO) SWOT Analysis, Strategy, Revenues and Profits

BioAlliance Pharma SA (Symbol:BIO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : France
Verisante Technology, Inc. (Symbol:VRS) SWOT Analysis, Strategy, Revenues and Profits

Verisante Technology, Inc. (Symbol:VRS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Canada
Algeta ASA (Symbol:ALGETA) SWOT Analysis, Strategy, Revenues and Profits

Algeta ASA (Symbol:ALGETA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
IMMUNOMEDICS, INC (Symbol:IMMU) SWOT Analysis, Strategy, Revenues and Profits

IMMUNOMEDICS, INC (Symbol:IMMU) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Hybrigenics S.A. (Symbol:ALHYG) SWOT Analysis, Strategy, Revenues and Profits

Hybrigenics S.A. (Symbol:ALHYG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Biodel Inc. (Symbol:BIOD) SWOT Analysis, Strategy, Revenues and Profits

Biodel Inc. (Symbol:BIOD) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Neuro-Hitech, Inc. (Symbol:NHPI) SWOT Analysis, Strategy, Revenues and Profits

Neuro-Hitech, Inc. (Symbol:NHPI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Photocure ASA (Symbol:PHO) SWOT Analysis, Strategy, Revenues and Profits

Photocure ASA (Symbol:PHO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

Photocure ASA (Photocure) is engaged in the development and marketing of pharmaceuticals and medical devices for the diagnosis and treatment of various types of cancer and precancerous conditions based ...

  • Industries : Pathology
  • Countries : United States, Norway
LEO Pharma A/S SWOT Analysis, Strategy, Revenues and Profits

LEO Pharma A/S SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Helix BioPharma Corp. (Symbol:HBP) SWOT Analysis, Strategy, Revenues and Profits

Helix BioPharma Corp. (Symbol:HBP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

Helix BioPharma Corp. (Helix) is a biopharmaceutical company engaged in developing innovative products for the prevention and treatment of cancer. The company's strategy is to commercialize its innovations ...

  • Industries : Pathology
  • Countries : Canada
Fisher & Paykel Healthcare Corporation Limited (Symbol:FPH) SWOT Analysis, Strategy, Revenues and Profits

Fisher & Paykel Healthcare Corporation Limited (Symbol:FPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
La Caisse centrale de la MSA - Strategic SWOT Analysis Review

La Caisse centrale de la MSA - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • November 2012
  • by Global Data

Summary La Caisse centrale de la MSA (CCMSA) is a financial service company, which provides welfare services. The company's social security policies cover family health, retirement and recovery, occupational ...

  • Industries : Pathology
  • Countries : France
Vasomedical, Inc. (Symbol:VASO) SWOT Analysis, Strategy, Revenues and Profits

Vasomedical, Inc. (Symbol:VASO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

Vasomedical, Inc. (Vasomedical) is a medical device company engaged in the design, manufacture and marketing of external counterpulsation systems that are used in the treatment of cardiogenic shock, ...

  • Industries : Pathology
  • Countries : United States

» Download Public Reports

About 17 000 reports
Company Report: Pathology in The United States and Ireland for Year 2013

Company Report: Pathology in The United States and Ireland for Year 2013

  • Company report
  • May 2013
  • 5 pages
  • by Corporation

... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...


» Read our Company Profiles

About 200 Companies

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Eli Lilly and Co.

United States

Lilly and Co.

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.